14 results
8-K/A
EX-99.1
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
such as mergers, acquisition, liquidation, dissolution, wind up of business, and deemed liquidation events, must be approved by the holders
8-K/A
EX-99.2
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
by such holder are then convertible. Certain actions such as mergers, acquisition, liquidation, dissolution, wind up of business, and deemed liquidation events
425
ELTX
Elicio Therapeutics Inc.
23 May 23
Business combination disclosure
8:42pm
, such as the six months to a year (plus additional time to resolve any potential litigation) it would take to dissolve the Company, wind down its business
8-K
ELTX
Elicio Therapeutics Inc.
23 May 23
Other Events
8:40pm
to resolve any potential litigation) it would take to dissolve the Company, wind down its business, run a third-party process for a sale of its assets
424B3
xpc16zb1hjk6ib6m
28 Apr 23
Prospectus supplement
4:07pm
CORRESP
fsf m77una3
13 Apr 23
Correspondence with SEC
12:00am
S-4/A
EX-10.26
b6bwvw5e01jwlz
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
06uf04oexz5x64o7r
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
424B3
jhsjbuy7k hyz8lmw2oc
24 May 22
Prospectus supplement
4:01pm
S-3
6lp06onwg0i3vnyd2mxj
16 May 22
Shelf registration
5:23pm
- Prev
- 1
- Next